Tenofovir disoproxil
CAS 201341-05-1
In Stock
Tenofovir disoproxil
Cat. No. STUB-API-TENOFOVIR-DISOPROXILCAS 201341-05-1In Stock
Technical Data
Cat. No.STUB-API-TENOFOVIR-DISOPROXIL
CAS201341-05-1
Mol. FormulaC19H30N5O10P
Mol. Weight519.448 g/mol
IUPAC[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
SMILESC[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C
InChIInChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1
InChI KeyJFVZFKDSXNQEJW-CQSZACIVSA-N
Purity—
Description
Overview
Tenofovir disoproxil is a drug used to treat chronic hepatitis B and to prevent and treat HIV / AIDS. It is usually recommended for use with other antivirals
Anant Labs manufacture and furnish high quality Tenofovir disoproxil impurities for global markets. Our Tenofovir disoproxil EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Tenofovir disoproxil201341-05-1Bis(POC)PMPA(r)-bis(poc)pmpabis-POC-PMPA2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxidetenofovir bis(isopropyloxycarbonyloxymethyl) esterF4YU4LON7I9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenineGS-4331
